Enkay Pharma Consulting Limited 06999699 false 2022-09-01 2023-08-31 2023-08-31 The principal activity of the company is 105 New Dover Road Digita Accounts Production Advanced 6.30.9574.0 true 06999699 2022-09-01 2023-08-31 06999699 2023-08-31 06999699 core:CurrentFinancialInstruments core:WithinOneYear 2023-08-31 06999699 bus:Micro-entities 2022-09-01 2023-08-31 06999699 bus:AuditExemptWithAccountantsReport 2022-09-01 2023-08-31 06999699 bus:FullAccounts 2022-09-01 2023-08-31 06999699 bus:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 06999699 bus:RegisteredOffice 2022-09-01 2023-08-31 06999699 bus:Director1 2022-09-01 2023-08-31 06999699 bus:Director2 2022-09-01 2023-08-31 06999699 bus:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 06999699 countries:EnglandWales 2022-09-01 2023-08-31 06999699 2021-09-01 2022-08-31 06999699 2022-08-31 06999699 core:CurrentFinancialInstruments core:WithinOneYear 2022-08-31 iso4217:GBP xbrli:pure

Registration number: 06999699

Enkay Pharma Consulting Limited

trading as Enkay Pharma Consulting Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 August 2023

 

Enkay Pharma Consulting Limited

trading as Enkay Pharma Consulting Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Enkay Pharma Consulting Limited

trading as Enkay Pharma Consulting Ltd

Company Information

Directors

Dr Hamida Koppiker

Dr N Koppiker

Registered office

115-116 Spon End
Coventry
Warwickshire
CV1 3HF

 

Enkay Pharma Consulting Limited

trading as Enkay Pharma Consulting Ltd

(Registration number: 06999699)
Balance Sheet as at 31 August 2023

2023
£

2022
£

Fixed assets

399,360

369,799

Current assets

3,947

8,768

Creditors: Amounts falling due within one year

(30,389)

(2,134)

Net current (liabilities)/assets

(26,442)

6,634

Total assets less current liabilities

372,918

376,433

Accruals and deferred income

(702)

(690)

 

372,216

375,743

Capital and reserves

372,216

375,743

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
115-116 Spon End
Coventry
Warwickshire
CV1 3HF
England

These financial statements were authorised for issue by the Board on 13 November 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £4,156 (2022 - £3,085). There are service charges, ground rent commitment,and guarantees. There were no contingencies.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2022 - 2).

 

Enkay Pharma Consulting Limited

trading as Enkay Pharma Consulting Ltd

(Registration number: 06999699)
Balance Sheet as at 31 August 2023

For the financial year ending 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 13 November 2023 and signed on its behalf by:
 

.........................................
Dr N Koppiker
Director